Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CorMedix licenses worldwide rights to Neutrolin

Executive Summary

Cardiorenal therapeutics start-up CorMedix has licensed from ND Partners LLC exclusive worldwide development, manufacturing, and marketing rights to Neutrolin--a late-stage antimicrobial liquid that "locks" a patient's central venous catheter (CVC) between hemodialysis sessions to prevent catheter-related blood stream infection (CRBSI) and clots, thus reducing the need for systemic/local antibiotics and prolonging catheter life.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies